Our results show that even lower levels of CRP (>3.25 μg/ml), measured within 14 days from onset, can help identify patients at risk of second ischemic events after experiencing a minor stroke and support the finding that even low levels of inflammation should be considered a vascular risk factor both in primary prevention and for stroke recurrence (8–10, 37, 38). The gene discussed is CRP; the disease is Stroke.